ライフサイエンスコーパス: cognitive behavioral therapy

1 treatment (the combination of fluoxetine and cognitive behavioral therapy).

2 scranial magnetic stimulation, and web-based cognitive behavioral therapy.

3 0-225 mg); or (4) switch to venlafaxine plus cognitive behavioral therapy.

4 All patients also received individual cognitive behavioral therapy.

5 ective serotonin reuptake inhibitor drugs or cognitive behavioral therapy.

6 abstinence from binge eating and purging to cognitive behavioral therapy.

7 so participated in weekly standardized group cognitive behavioral therapy.

8 s used in conjunction with weekly outpatient cognitive behavioral therapy.

9 weeks and participated in weekly individual cognitive behavioral therapy.

10 ) or placebo for 11 weeks, plus standardized cognitive-behavioral therapy.

11 double placebo (N=39) while receiving weekly cognitive-behavioral therapy.

12 o therapist-led and therapist-assisted group cognitive-behavioral therapy.

13 dividual psychotherapy, pharmacotherapy, and cognitive-behavioral therapy.

14 ht twice daily) or placebo along with weekly cognitive-behavioral therapy.

15 oms that are refractory to pharmacologic and cognitive-behavioral therapies.

16 supportive psychotherapy compared to that of cognitive-behavioral therapy; 2) whether a two-stage med

17 -40 mg); (2) switch to a different SSRI plus cognitive behavioral therapy; (3) switch to venlafaxine

18 Cognitive behavioral therapy achieved lower posttreatmen

19 onged tobacco abstinence rates compared with cognitive behavioral therapy alone after 1 year of treat

20 Under SC, cases were referred to cognitive behavioral therapy, an evidence-based therapy

21 eceived 12-weeks' open-label varenicline and cognitive behavioral therapy and 87 met abstinence crite

22 l treatment with an SSRI, the combination of cognitive behavioral therapy and a switch to another ant

23 or matched placebo, plus weekly computerized cognitive behavioral therapy and biweekly individual cou

24 Psychological interventions such as cognitive behavioral therapy and contingency management

25 treatment were randomly assigned to receive cognitive behavioral therapy and double-blind vareniclin

26 ted with 12 weekly sessions of manual-guided cognitive behavioral therapy and either 50 mg/day of nal

27 s which have shown promising results include cognitive behavioral therapy and graded exercise therapy

28 The dissemination of computer-based cognitive behavioral therapy and improved evidence suppo

29 Cognitive behavioral therapy and interpersonal psychothe

30 Thus, the therapeutic effects of cognitive behavioral therapy and naltrexone may be syner

31 and SUDs, and treatment modalities including cognitive behavioral therapy and pharmacotherapy demonst

32 Substantial evidence supports the use of cognitive behavioral therapy and selective serotonin reu

33 Although cognitive behavioral therapy and selective serotonin-reu

34 Both cognitive behavioral therapy and sertraline reduced the

35 Other forms of cognitive behavioral therapy and topiramate also increas

36 have emerged as having established efficacy: cognitive-behavioral therapy and antidepressant medicati

37 imia yield extremely high relapse rates, but cognitive-behavioral therapy and family-based treatment

38 en initiated after an acute episode, whereas cognitive-behavioral therapy and group psychoeducation a

39 Cognitive-behavioral therapy and interpersonal therapy h

40 boratory work continue to support the use of cognitive-behavioral therapy and operant behavioral ther

41 Cognitive-behavioral therapy and operant behavioral ther

42 Nonpharmacologic interventions such as cognitive-behavioral therapy and stress management may b

43 ore a 12-week randomized controlled trial of cognitive-behavioral therapy and/or contingency manageme

44 rmacological therapies (education, exercise, cognitive behavioral therapy) and pharmacological therap

45 ic antidepressants, cardiovascular exercise, cognitive behavioral therapy, and patient education.

46 terans with PTSD will receive evidence-based cognitive-behavioral therapy, and the Army has developed

47 amphetamine salts in robust doses along with cognitive behavioral therapy are effective for treatment

48 , family therapy, interpersonal therapy, and cognitive-behavioral therapy are described.

49 ms were also significantly more improved for cognitive behavioral therapy (beta = -0.41; 95% CI, -0.6

50 behavioral interventions and Internet-based cognitive-behavioral therapy both show promise for use i

51 ChRs) before and after treatment with either cognitive-behavioral therapy, bupropion HCl, or pill pla

52 ers is an integral element of trauma-focused cognitive behavioral therapy, but little is known about

53 A large study found that a combination of cognitive behavioral therapy (CBT) and antidepressant me

54 On the basis of moderate-strength evidence, cognitive behavioral therapy (CBT) and antidepressants l

55 parative effectiveness and adverse events of cognitive behavioral therapy (CBT) and pharmacotherapy f

56 n, can augment the effects of exposure-based cognitive behavioral therapy (CBT) for obsessive-compuls

57 Cognitive behavioral therapy (CBT) for social anxiety di

58 Applications of Fuzzy Trace Theory to Cognitive Behavioral Therapy (CBT) for youth at risk for

59 They ascertain that in cognitive behavioral therapy (CBT) high priority is give

60 3 randomized controlled trials of individual cognitive behavioral therapy (CBT) in a primary care set

61 analysis was used to estimate the benefit of cognitive behavioral therapy (CBT) in pregnant and postp

62 Cognitive behavioral therapy (CBT) is an effective treat

63 se We evaluated the effect of Internet-based cognitive behavioral therapy (CBT) on sexual functioning

64 We determined whether individual cognitive behavioral therapy (CBT) reduces depression in

65 Although cognitive behavioral therapy (CBT) represents the criter

66 Before cognitive behavioral therapy (CBT), 48 adults (25 GAD an

67 Depression Study evaluated fluoxetine (FLX), cognitive behavioral therapy (CBT), and FLX/CBT combinat

68 CALM allowed choice of cognitive behavioral therapy (CBT), medication, or both;

69 e of our study was to evaluate the effect of cognitive behavioral therapy (CBT), physical exercise (P

70 to predict subsequent treatment response to cognitive behavioral therapy (CBT).

71 brain structure in patients with PTSD after cognitive behavioral therapy (CBT).

72 o assess the clinical efficacy and safety of cognitive-behavioral therapy (CBT) against education (ED

73 tcomes of two active treatments, maintenance cognitive-behavioral therapy (CBT) and manualized psycho

74 The authors evaluated the efficacy of cognitive-behavioral therapy (CBT) and two antidepressan

75 nced treatment combining pharmacotherapy and cognitive-behavioral therapy (CBT) boosts response and p

76 review, the authors examine the efficacy of cognitive-behavioral therapy (CBT) for adolescents with

77 l quality of randomized controlled trials of cognitive-behavioral therapy (CBT) for depression using

78 posure and ritual prevention, an established cognitive-behavioral therapy (CBT) for OCD.

79 This case study describes cognitive-behavioral therapy (CBT) for pathological gamb

80 the efficacy of a computer-based version of cognitive-behavioral therapy (CBT) for substance depende

81 authors evaluated the effectiveness of brief cognitive-behavioral therapy (CBT) for the prevention of

82 Cognitive-behavioral therapy (CBT) has documented effica

83 Various approaches to cognitive-behavioral therapy (CBT) have been shown to be

84 d accelerates a full course of comprehensive cognitive-behavioral therapy (CBT) in adults with genera

85 We examined the effects of cognitive-behavioral therapy (CBT) in patients with anxi

86 ther long-term treatment with doxycycline or cognitive-behavioral therapy (CBT) in reducing fatigue s

87 are probably slightly smaller than those of cognitive-behavioral therapy (CBT) in the acute phase of

88 rs compared psychoanalytic psychotherapy and cognitive-behavioral therapy (CBT) in the treatment of b

89 ects of a 10-session, telephone-administered cognitive-behavioral therapy (CBT) intervention on PTSD,

90 Although exposure-based cognitive-behavioral therapy (CBT) is an effective treat

91 Cognitive-behavioral therapy (CBT) is an effective treat

92 Cognitive-behavioral therapy (CBT) is effective for pedi

93 Research suggests that cognitive-behavioral therapy (CBT) is the most effective

94 tention bias modification therapy (ABMT) and cognitive-behavioral therapy (CBT) may have complementar

95 ion of up to 6 sessions (across 12 weeks) of cognitive-behavioral therapy (CBT) modified for the prim

96 ive imipramine, up to 300 mg/d, only (n=83); cognitive-behavioral therapy (CBT) only (n=77); placebo

97 pressive disorder in adolescents may include cognitive-behavioral therapy (CBT) or a selective seroto

98 form the first-line treatment choice between cognitive-behavioral therapy (CBT) or an antidepressant

99 e depressed patient benefits moderately from cognitive-behavioral therapy (CBT) or pharmacotherapy, s

100 moderator and index of symptom change during cognitive-behavioral therapy (CBT) or selective serotoni

101 trategy of fluoxetine and relapse-prevention cognitive-behavioral therapy (CBT) to determine effects

102 ms irrespective of diagnosis, trauma-focused cognitive-behavioral therapy (CBT) was more effective th

103 Cognitive-behavioral therapy (CBT) was significantly mor

104 andomized clinical trial was to test whether cognitive-behavioral therapy (CBT) was superior to fibro

105 Pharmacotherapy, cognitive-behavioral therapy (CBT), and psychodynamic th

106 te the relative effectiveness of fluoxetine, cognitive-behavioral therapy (CBT), and the combination

107 ) evaluates the effectiveness of fluoxetine, cognitive-behavioral therapy (CBT), and their combinatio

108 itial 12 weeks of treatment with fluoxetine, cognitive-behavioral therapy (CBT), combination treatmen

109 ficacy of psychodynamic therapy with that of cognitive-behavioral therapy (CBT), hypothesizing nonsig

110 orted findings of a clinical trial comparing cognitive-behavioral therapy (CBT), psychodynamic therap

111 ne the efficacy of individually administered cognitive-behavioral therapy (CBT), relative to clinical

112 ral therapy (CCBT) in comparison to standard cognitive-behavioral therapy (CBT).

113 or venlafaxine) or a medication switch plus cognitive-behavioral therapy (CBT).

114 ke inhibitor or venlafaxine, with or without cognitive-behavioral therapy (CBT).

115 dependence: contingency management (CM) and cognitive-behavioral therapy (CBT).

116 All studies involved cognitive-behavioral therapy (CBT).

117 s before and after symptom reduction through cognitive-behavioral therapy (CBT).

118 strated benefits for pharmacotherapy and for cognitive-behavioral therapy (CBT).

119 eks of treatment with either escitalopram or cognitive-behavioral therapy (CBT).

120 ve serotonin reuptake inhibitors (SSRIs) and cognitive-behavioral therapy (CBT).

121 trial evaluating computer-based training for cognitive-behavioral therapy (CBT4CBT) in 77 heterogeneo

122 recommended in combination with established cognitive-behavioral therapies (CBTs) for posttraumatic

123 apist-supported method for computer-assisted cognitive-behavioral therapy (CCBT) in comparison to sta

124 symptoms treated with medication, the use of cognitive behavioral therapy compared with relaxation wi

125 Responders and partial responders in the cognitive behavioral therapy condition maintained their

126 uidelines recommend adding antipsychotics or cognitive-behavioral therapy consisting of exposure and

127 aimed to develop and evaluate a computerized cognitive-behavioral therapy dental anxiety intervention

128 aimed at increasing cognitive control using cognitive behavioral therapies dependent on the intact d

129 s used to compare the efficacy of manualized cognitive-behavioral therapy developed particularly for

130 onding to chronic stress, and trauma-focused cognitive behavioral therapy documents that these treatm

131 and substance use as well as medication and cognitive behavioral therapy elements targeting PTSD and

132 of modalities, including behavioral therapy, cognitive-behavioral therapy, emotion-focused therapy, a

133 udies of fluoxetine, combined fluoxetine and cognitive behavioral therapy, escitalopram, and collabor

134 severe and persistent PTS via trauma-focused cognitive behavioral therapy; evidence is lacking for ps

135 We found good evidence that cognitive-behavioral therapy, exercise, spinal manipulat

136 cy for chronic or subacute low back pain are cognitive-behavioral therapy, exercise, spinal manipulat

137 Recent studies showed that cognitive-behavioral therapy failed to produce superior

138 Treatment with cognitive-behavioral therapy, fluoxetine hydrochloride,

139 ions, DBS could augment the effectiveness of cognitive behavioral therapies for OCD.

140 d controlled trial assessing the efficacy of cognitive behavioral therapy for 86 symptomatic adults w

141 h should assess the delivery of manual-based cognitive behavioral therapy for anxiety disorders by me

142 cognitive behavioral therapy for depression, cognitive behavioral therapy for anxiety, and behavioral

143 and there were more treatment responders in cognitive behavioral therapy for both the Clinical Globa

144 atment with residential treatment plus group cognitive behavioral therapy for depression delivered by

145 Providing group cognitive behavioral therapy for depression to clients w

146 al treatment (59 youths [34% of the sample]; cognitive behavioral therapy for depression, cognitive b

147 Sixteen 2-hour group sessions of cognitive behavioral therapy for depression.

148 dults with chronic insomnia disorder in whom cognitive behavioral therapy for insomnia (CBT-I) alone

149 Purpose Cognitive behavioral therapy for insomnia (CBT-I) and Ta

150 P recommends that all adult patients receive cognitive behavioral therapy for insomnia (CBT-I) as the

151 ed stress reduction (MBSR) is noninferior to cognitive behavioral therapy for insomnia (CBT-I) for th

152 Cognitive behavioral therapy for insomnia (CBT-I) improv

153 ts associated with pharmacologic approaches, cognitive behavioral therapy for insomnia (CBT-i) is now

154 Although cognitive behavioral therapy for insomnia (CBT-I) is the

155 elated stimuli (SS), which can be treated by cognitive behavioral therapy for insomnia (CBT-I).

156 nd (3) evidence-based pharmacotherapy and/or cognitive behavioral therapy for patients with persisten

157 avioral interventions for trauma in schools, cognitive behavioral therapy for PTSD, structured psycho

158 t, and utilize functional rehabilitation and cognitive behavioral therapy for the individual and fami

159 re recommended in conjunction with drugs and cognitive behavioral therapy for the treatment of impair

160 ffecting other neurotransmitter systems, and cognitive behavioral therapy for the treatment of pediat

161 ults with insomnia were randomly assigned to cognitive-behavioral therapy for insomnia (CBT-I), tai c

162 for insomnia, typically delivered as part of cognitive-behavioral therapy for insomnia (CBT-I).

163 r seasonal affective disorder (SAD), data on cognitive-behavioral therapy for SAD (CBT-SAD) are promi

164 h as fear of reinjury) and the adaptation of cognitive-behavioral therapy for special pain groups (e.

165 t group, children in the social learning and cognitive behavioral therapy group reported greater base

166 rt group, parents in the social learning and cognitive behavioral therapy group reported greater base

167 Cognitive behavioral therapy has been shown to be more e

168 Enhanced cognitive behavioral therapy has improved symptoms in ad

169 Self-guided internet-based cognitive behavioral therapy (iCBT) has the potential to

170 tudy of a newly developed internet-delivered cognitive behavioral therapy (ICBT) that emphasized expo

171 tenance pharmacotherapy with varenicline and cognitive behavioral therapy improved prolonged tobacco

172 y across both groups, as well as response to cognitive-behavioral therapy in a subset of 53 patients.

173 Research evidence supports the efficacy of cognitive-behavioral therapy in the treatment of drug-re

174 Approaches to treatment should include cognitive-behavioral therapy (including habit reversal o

175 on is based on well-established face-to-face cognitive behavioral therapy incorporating the primary c

176 lexible-dose sertraline hydrochloride) only, cognitive behavioral therapy informed psychotherapy (CBT

177 A 3-session social learning and cognitive behavioral therapy intervention or an educatio

178 Prior research suggests that cognitive behavioral therapy is a particularly effective

179 Cognitive behavioral therapy is an effective treatment f

180 nd well to the use of an antidepressant, and cognitive-behavioral therapy is a useful approach for ma

181 Cognitive-behavioral therapy is effective in treating ne

182 At present, cognitive-behavioral therapy is the psychological treatm

183 e of the most effective insomnia treatments, cognitive behavioral therapy, is significantly limited.

184 Cognitive behavioral therapy, lisdexamfetamine, SGAs, an

185 at extinction procedures, via exposure-based cognitive behavioral therapy, make up one of the predomi

186 ndary analyses suggest that bupropion SR and cognitive behavioral therapy may be effective treatments

187 ths were randomized to 1 of 4 interventions (cognitive behavioral therapy, medication, combination, o

188 ceiving supportive psychotherapy (n = 24) or cognitive behavioral therapy (n = 27).

189 , a self-help booklet based on principles of cognitive behavioral therapy (n = 28), or repeated asses

190 he effect of nortriptyline hydrochloride and cognitive-behavioral therapy on smoking treatment outcom

191 psychosocial interventions for chronic pain: cognitive-behavioral therapy, operant behavioral therapy

192 ndomized to 12 individual sessions of either cognitive behavioral therapy or relaxation with educatio

193 mmends that clinicians select between either cognitive behavioral therapy or second-generation antide

194 interpersonal and social rhythm therapy, or cognitive-behavioral therapy) or collaborative care, a t

195 mg per day), a combination of sertraline and cognitive behavioral therapy, or a placebo drug for 12 w

196 k, low-level laser therapy, operant therapy, cognitive behavioral therapy, or spinal manipulation (lo

197 massage therapy, spinal manipulation, yoga, cognitive-behavioral therapy, or progressive relaxation

198 for combination therapy (P<0.001), 59.7% for cognitive behavioral therapy (P<0.001), and 54.9% for se

199 Cognitive behavioral therapy plus a switch to either med

200 ve of this study was to test the efficacy of cognitive-behavioral therapy plus hypnosis (CBTH) to con

201 In addition, cognitive-behavioral therapy plus medication was superio

202 Cognitive behavioral therapy produced larger improvement

203 y intervention added an 8-session structured cognitive behavioral therapy program with up to 4 additi

204 Cognitive behavioral therapy rapidly affects automatic p

205 Cognitive behavioral therapy reduced primary anxiety sym

206 , or social phobia to receive 14 sessions of cognitive behavioral therapy, sertraline (at a dose of u

207 vioral category, graded exercise therapy and cognitive behavioral therapy showed positive results and

208 vement, including behavioral options such as cognitive behavioral therapy, slow breathing and hypnosi

209 erventions with interpersonal psychotherapy, cognitive behavioral therapy, supportive psychotherapy,

210 icant differences in long-term outcome among cognitive behavioral therapy, systematic behavioral fami

211 order randomly assigned to 12 to 16 weeks of cognitive behavioral therapy, systemic behavioral family

212 udies have shown that telephone-administered cognitive-behavioral therapy (T-CBT) is superior to form

213 suggest better long-term outcomes following cognitive-behavioral therapy tailored for SAD (CBT-SAD)

214 lowing percentages of the overall variation: cognitive-behavioral therapy techniques, 16%; family the

215 lowing percentages of the overall variation: cognitive-behavioral therapy techniques, 23%; family the

216 attitudes were more likely to endorse use of cognitive-behavioral therapy techniques, as were those i

217 , sedation, and restlessness associated with cognitive behavioral therapy than with sertraline.

218 ndomly assigned to a 10-session standardized cognitive-behavioral therapy (the Cognitive-Behavioral I

219 entions (fluoxetine hydrochloride treatment, cognitive behavioral therapy, their combination, or plac

220 omen in Washington, District of Columbia, to cognitive behavioral therapy vs. usual care to decrease

221 This was a 2 (nortriptyline vs placebo) x 2 (cognitive-behavioral therapy vs control) x 2 (history of

222 Group comprehensive cognitive behavioral therapy was administered weekly for

223 Cognitive behavioral therapy was associated with fewer d

224 Cognitive behavioral therapy was provided weekly during

225 Cognitive behavioral therapy was the EBT most frequently

226 Cognitive-behavioral therapy was more effective for part

227 Cognitive-behavioral therapy was significantly more rapi

228 Cognitive-behavioral therapy was significantly superior

229 Cognitive-behavioral therapy was superior to supportive

230 ressive symptoms, whereas family therapy and cognitive-behavioral therapy were more effective for dep

231 he efficacy of online-based dissemination of cognitive behavioral therapies, which have demonstrated

232 bination therapy had a greater response than cognitive behavioral therapy, which was equivalent to se

233 ts with bulimia nervosa who had responded to cognitive behavioral therapy with complete abstinence fr

234 Although cognitive behavioral therapy with or without selective s

235 To compare prolonged exposure, a type of cognitive behavioral therapy, with present-centered ther